CRDF · Cardiff Oncology, Inc. · Webcasts, Transcripts & Audio
$1.10
+0.04 (+3.77%)
At close · Oct 9
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 11, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Management has performed an analysis and concluded that there exists a substantial doubt about the Company's ability to continue as a going concern.”View the 10-Q filed Aug 11, 2026
Market Cap
$82.85M
Shares
77.80M
Volume · Oct 9
38.02K
Avg daily vol (3M)
1.05M
Cardiff Oncology, Inc. Webcasts
Earnings calls, investor updates, investor days and conferences for Cardiff Oncology, Inc. (CRDF), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲18.7%
$92,576
−$4.24M
'19 Q4
20-02-27
▲9.6%
$68,000
−$4.09M
'20 Q1
20-05-07
▲12.1%
$43,000
−$4.12M
'20 Q2
20-08-11
▲163.1%
$136,000
−$4.50M
'20 Q3
20-11-05
▲5.9%
$72,000
−$5.18M
'21 Q1
21-05-06
▲11.8%
$133,000
−$9.44M
'21 Q4
22-02-24
▲2.8%
$74,000
−$10.99M
'22 Q1
22-05-05
▲8.1%
$93,000
−$8.57M
'22 Q3
22-11-03
▼3.8%
$128,000
−$8.70M
'22 Q4
23-03-02
▲51.6%
$141,000
−$9.73M
'23 Q3
23-11-02
▲21.9%
$156,000
−$9.34M
'23 Q4
24-02-29
▲147%
$205,000
−$10.01M
'24 Q1
24-05-02
▲50.9%
$163,000
−$11.78M
'24 Q2
24-08-08
▼3.8%
$150,000
−$11.79M
'24 Q4
25-02-27
▼25.8%
$121,000
−$13.94M
'25 Q2
25-07-29
LATEST
▼62.4%
$41,000
−$12.35M
'26 Q1
26-06-03
Conference
Investor event
2026-09-14
Cardiff Oncology, Inc. (CRDF) September 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-06-04
Cardiff Oncology, Inc. (CRDF) June 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-06-03
Cardiff Oncology, Inc. (CRDF) Q1 2026 Earnings Call
Revenue
$41,000
▼ 62.4% YoY Diluted EPS
$-0.18
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-01-27
Cardiff Oncology, Inc. (CRDF) January 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY25 · Q2
2025-07-29
Cardiff Oncology, Inc. (CRDF) Q2 2025 Earnings Call
Revenue
$121,000
▼ 25.8% YoY Diluted EPS
$-0.21
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-27
Cardiff Oncology, Inc. (CRDF) Q4 2024 Earnings Call Transcript
Confident tone
Lead mCRC program CRDF-004 / onvansertib efficacy
Breast cancer preclinical program
Comparative reference to Pfizer BREAKWATER
Revenue
$150,000*
▼ 3.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q2
2024-08-08
Cardiff Oncology, Inc. (CRDF) Q2 2024 Earnings Call Transcript
Positive tone
Lead mCRC program CRDF-004
Pancreatic cancer program pivot
Additional cancer indications and preclinical work
Revenue
$163,000
▲ 50.9% YoY Diluted EPS
$-0.26
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-02
Cardiff Oncology, Inc. (CRDF) Q1 2024 Earnings Call Transcript
Confident tone
First-line RAS-mutated mCRC lead program
AACR 2024 data presentations
RAS wild-type mCRC opportunity
Revenue
$205,000
▲ 147% YoY Diluted EPS
$-0.22
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-29
Cardiff Oncology, Inc. (CRDF) Q4 2023 Earnings Call Transcript
Confident tone
ONSEMBLE trial randomized data release
First-line mCRC program / CRDF-004
Pancreatic cancer program
Revenue
$156,000*
▲ 21.9% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-11-02
Cardiff Oncology, Inc. (CRDF) Q3 2023 Earnings Call Transcript
Revenue
$141,000
▲ 51.6% YoY Diluted EPS
$-0.22
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-03-02
Cardiff Oncology, Inc. (CRDF) Q4 2022 Earnings Call
Revenue
$128,000*
▼ 3.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-03
Cardiff Oncology, Inc. (CRDF) Q3 2022 Earnings Call
Revenue
$93,000
▲ 8.1% YoY Diluted EPS
$-0.20
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-05-05
Cardiff Oncology, Inc. (CRDF) Q1 2022 Earnings Call
Revenue
$74,000
▲ 2.8% YoY Diluted EPS
$-0.25
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-24
Cardiff Oncology, Inc. (CRDF) Q4 2021 Earnings Call
Revenue
$133,000*
▲ 11.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q1
2021-05-06
Cardiff Oncology, Inc. (CRDF) Q1 2021 Earnings Call
Revenue
$72,000
▲ 5.9% YoY Diluted EPS
$-0.14
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q3
2020-11-05
Cardiff Oncology, Inc. (CRDF) Q3 2020 Earnings Call
Revenue
$136,000
▲ 163.1% YoY Diluted EPS
$-0.19
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-08-11
Cardiff Oncology, Inc. (CRDF) Q2 2020 Earnings Call
Revenue
$43,000
▲ 12.1% YoY Diluted EPS
$-0.51
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-07
Cardiff Oncology, Inc. (CRDF) Q1 2020 Earnings Call
Revenue
$68,000
▲ 9.6% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-02-27
Cardiff Oncology, Inc. (CRDF) Q4 2019 Earnings Call
Revenue
$92,576*
▲ 18.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–19 of 19 webcasts